In a statement, Neuralink has confirmed that it has recently received permission from an independent review board in the US to begin recruiting participants for its first human trial. The study will focus on testing the safety and functionality of an experimental neurotechnology device that can collect and analyse brain signals. Neuralink, a company founded by Elon Musk, is seeking individuals with paralysis caused by vertical spinal cord injury or ALS. Participants will have a brain-computer interface (BCI) surgically implanted in a region of the brain that controls movement. The goal of the study is to enable participants to control a computer cursor or keyboard using only their thoughts.
What is this page?
You are reading a summary article on the Privacy Newsfeed, a free resource for DPOs and other professionals with privacy or data protection responsibilities helping them stay informed of industry news all in one place. The information here is a brief snippet relating to a single piece of original content or several articles about a common topic or thread. The main contributor is listed in the top left-hand corner, just beneath the article title.
The Privacy Newsfeed monitors over 300 global publications, of which more than 5,750 summary articles have been posted to the online archive dating back to the beginning of 2020. A weekly roundup is available by email every Friday.
